Results: Sixteen subjects (43%) were atopic, 6 (16%) reported past diagnosis of asthma. No subject was assuming drugs or had suffered from respiratory infections in the last month. All subjects had normal lung function tests. With HViso 10 subjects had EI-B and 12 had EI-VCD. With HVhypo 8 subjects had EI-B and 15 EI-VCD. Eighteen subiects (49%) had Ddef (serum 25hydroxycholecalcipherol , 25 ng/mL). Serum levels of vitamin D were significantly lower in athletes with than in those without EI-VCD, either with HViso (19.1 6 1.8 vs 25.7 6 1.5 ng/mL; P ¼ 0.013) or with HVhypo (20.2 6 1.9 vs 26.2 6 1.8 ng/mL; P ¼ 0.029). No influence of vitamin D on EI-B could be demonstrated. Vitamin D levels were significantly related to the decrease in MIF50 (as % of baseline) during the test (HViso: r ¼ 0.41; P , 0.015 and HVipo: r ¼ 0.42; P ¼ 0.017). Conclusions: Our young athletes had a high prevalence of paradoxical vocal cord adduction during HV, which was strongly associated to Ddef. The high prevalence of Ddef was expected, since the study was conducted during winter in a town located beyond 458 latitude. Vitamin D deficiency may favour laryngospasm by decreasing calcium availability, ATP production and Ca-ATPase pump activity in the striate muscle cell, with consequent tetanic contraction and delayed relaxation. The fact that alkalosis worsens hypocalcemia accounts for the higher prevalence of laryngospasm observed during HVhypo. 3 Mexico. Background: Spirometry is a very useful clinical test to evaluate pulmonary function in asthma. However pulmonary function could be affected by the sex, time of clinical evolution, lung age (LA) and chronological age (CA). The aim of this study was to evaluate LA/CA as index of clinical improvement or severity in asthma patients. Methods: The tenets of the Declaration of Helsinki were followed, and all patients gave their informed consent to participate in this study. Asthma severity was evaluated according with GINA classification. Spirometry was performed at the beginning of this study, at 46 days, 96 days, 192 days and after 8 months. Statistical analysis was performed using t test, 2-way ANOVA test, correlation and multiple regression models as well as ROC curves were also performed, a P , 0.05 was considered as significant. Results: 70 asthma patients were included (22 male and 48 female), mean CA was 35-years old; mean LA was 48-years with a LA/CA index ¼ 1.4, time of clinical evolution was 13 years. A LA/CA index ¼ 1 (range 0.5 to 0.9) was observed in asymptomatic patients. LA/CA index over 1 were related with airway inflammation, and a LA/CA index more than 2 correlated with GINA step 3. Interestingly when we analyzed CA and LA, we observed that in female group more than 10 years of difference between CA and LA, (GINA Step2 and 3); while in male we observed (GINA Step1, Step2 and Step3). LA/CA index # 1 was considered as normal. Conclusions: LA/CA index is a good as clinical indicator of clinical improvement or severity in asthma patients in with excellent correlation of pulmonary function and age.
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Transition from Cough Variant Asthma to Asthma With Reduced FEV1
June-Hyuk Lee, 1 Sung Woo Park, 2 An-Soo Jang, 1 DoJin Kim, 1 and Choon-Sik Park 1 . 1 Respiratory and allergy, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea; 2 Division of Respiratory and Allergy Medicine, College of Medicine, Soonchunhyang University Hospital, Bucheon, South Korea. Background: Cough variant asthma (CVA) is one of the most common causes of chronic cough. It may have been thought to be as a pre-asthmatic condition. Some CVA patients show decreased lung function after diagnosed as a CVA. This study aimed to see differences of clinical characteristics between CVA with preserved FEV1 and CVA with reduced FEV1 after diagnosis of CVA. Methods: We searched medical records from January 2007 to May 2011. Thousand six hundred sixty two patients were diagnosed as CVA. Among 1662 CVA patients, 284 patients were revisited to hospital with symptom of chest tightness. Results: Among 284, fifty two (18.3%) patients showed reduced FEV1. Mean interval between diagnosis of CVA and reducing of FEV1 was 305.5 days. There was no significant difference of level of PC20 or other pulmonary functional values between FEV1-reduced group and -preserved group. Conclusions: Only small portion of CVA patients was transformed to asthma with reduced FEV1, and most of CVA still preserved their lung function. Objective: The purpose of this study is to report the cases of asthma diagnosed in the Allergy service from a Third level medical centre since its creation in July 2005. Methods: This is a descriptive, retrospective, transversal study from July 2005 to February 2011. Selected medical records of patients apply for diagnostic criteria for an allergy disease. GINA guide 2009 was used to make diagnosis of asthma. Patients were classified by age and sex and find out how many of them skin prick test were made and also how many patients began treatment with immunotherapy. Results: Thirteen thousand seven hundred thirty seven consultations were attended in the Allergy service between the time period mentioned above. Two thousand three hundred thirty seven medical records of patients were selected, 1608 patients applied for a specific diagnosis for an allergy disease as follows: Asthma 411, Atopic Conjunctivitis 58, Atopic Dermatitis 180, Allergic Rhinitis 869, Urticaria 90. Four hundred eleven patients completed criteria for Asthma. Two hundred thirteen (51.8%) patients were female, 198 (48.2%) patients were male. Two hundred twenty seven (55.2%) patients were found to be in the range of 0 to 9 years, 141 (62.1%) of them were between 5 to 9 years. The majority of asthma patients were males in the range of 5 to 9 years. Some increase in asthma cases were found in females between 30 and 40 years of age, 75 (35.2%) of total female cases, about 18% of total cases of asthma. Skin prick test were made in 164 (40%) asthma patients. In 134 were positive to a specific allergen and began immunotherapy. Conclusions: Asthma represents the second highest incidence in allergy diseases among children. However, it is the main cause of hospitalization among allergy diseases because of the presence of crises that increases the cost of medical attention. It is very important therefore to make a good diagnosis of asthma early on in order to bring adequate treatment, including immunotherapy. Education to these patients is also an important task, mainly in children. Background: In 2011, we conducted a comprehensive asthma survey in Latin America with a 3-fold purpose: to explore the realities of living with asthma, to identify the disconnect between expectations in asthma management and the patient experience, and to identify unmet needs in asthma management. The Latin America Asthma Insight and Management (LA AIM) survey was modeled on similar programs in the US, Europe and Canada, and the Asia-Pacific region. Methods: Face-to-face interviews of approximately 35 minutes' duration were conducted with respondents drawn from a national probability sample. The survey was designed to include 2000 patients (400 patients/location) across countries in Latin America (Argentina, Brazil, Mexico, Venezuela) and the Commonwealth of Puerto Rico. Survey questions were organized under the topics of asthma burden; impact of asthma on patients' activities, lifestyles, and work productivity; emotional burden; defining and characterizing symptoms; seasonal influences on symptoms; triggers; most bothersome symptoms; and patient perceptions about current levels of control. Results: The results from the LA AIM survey will become available in November 2011. In the 2009 US AIM survey, 1 2500 asthma patients aged $12 years (adults, n ¼ 2186, and parents of adolescent respondents) were interviewed by phone. Participants had a diagnosis of asthma, had taken asthma medication, or experienced an asthma attack within 12 months of the survey. Respondents in the patient sample were predominantly female (69%, n ¼ 1732), aged $35 years (73%, n ¼ 1819), and had "not wellcontrolled" or "very poorly controlled" asthma (71%), using National Asthma Education Prevention Program guideline criteria. One in 4 respondents experienced symptom worsening at least weekly over the past 12 months: 11% reported asthma exacerbations most days; another 14% reported them at least twice weekly. Conclusions: The US AIM survey provides a comprehensive depiction of the current state of asthma burden and patient perceptions in the United States. The LA AIM survey provides a view of the state of asthma across 5 distinct Latin American cultures.
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